News
UCB brings first therapy for rare disease TK2d to EU
The EU has approved UCB's Kygevvi for rare disease TK2d, and Sanofi's acute GvHD therapy Rezurock, in a pair of decisions announced this morning.
News
Amgen's BiTE for lung cancer backed for EU approval
Amgen's fast-growing bispecific T-cell engager Imdylltra should be cleared as a second-line therapy for small cell lung cancer, said the CHMP.
News
Touchdown for Rocket as its first gene therapy gets US okay
Rocket Pharma has won FDA approval for the first gene therapy for LAD-I, a devastating genetic disorder causing severe vulnerability to infections.
Market Access
BIO-Europe Spring 2026: In conversation with Marjorie Sidhou...
Marjorie Sidhoum, vice president of business development & corporate communication at Kainova Therapeutics, discusses their immuno-oncology pipeline.
News
Corcept gets FDA OK for first-in-class ovarian cancer drug
Corcept shares surge on FDA approval of Lifyorli, a first-in-class selective glucocorticoid receptor antagonist for ovarian cancer.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
